ArticleFrontiers in immunology2024

Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes.

Ga Young Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.